Skip to main content
HeartCited

NMN (Nicotinamide Mononucleotide) के लिए Arterial Stiffness

C

Single RCT showed improved pulse wave velocity in middle-aged adults. NAD+ restoration mechanism is compelling. Larger cardiovascular-specific trials are ongoing.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnmn\u0026condition\u003Darterial\u002Dstiffness'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
निष्कर्ष

            
            
Single RCT showed improved pulse wave velocity in middle-aged adults. NAD+ restoration mechanism is compelling. Larger cardiovascular-specific trials are ongoing.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
2

        
अध्ययन

    

    

        
100

        
प्रतिभागी

    

    

        
            
            ↑
            
        
        
Positive

    

    

        C

        
ग्रेड

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
सामान्य रूप से उपयोग की जाने वाली खुराकें

                

                    
                    

                        
general:

                        
250-500 mg/day

                    

                    
                    

                        
antiagingprotocols:

                        
500-1,000 mg/day

                    

                    
                

                
                

                    अधिकतम सीमा: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e
                

                
            

            

            

            
            

                सेवन का सर्वोत्तम समय: Morning on empty stomach or with light meal; sublingual for enhanced bioavailability
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
रिपोर्ट किए गए दुष्प्रभाव

                    
    
                        
                        
  • 
                            ⚠
                            Generally well-tolerated
                        
    • 
                        
                        
  • 
                            ⚠
                            Mild gastrointestinal discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Flushing (rare)
                        
    • 
                        
                        
  • 
                            ⚠
                            Headache (rare)
                        
    • 
                        
                    

                

                

                
                

                    
ज्ञात अंतःक्रियाएँ

                    
    
                        
                        
  • 
                            ●
                            May interact with NAD+-dependent medications
                        
    • 
                        
                        
  • 
                            ●
                            Theoretical interaction with diabetes medications (may affect glucose metabolism)
                        
    • 
                        
                    

                

                

                
                

                    

                        सहनीय अधिकतम सेवन: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e
                    

                

                
            

            

                कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does NMN (Nicotinamide Mononucleotide) help with Arterial Stiffness?
            
        
        

            Based on 2 studies with 100 participants, there is limited but promising evidence that NMN (Nicotinamide Mononucleotide) may support Arterial Stiffness management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much NMN (Nicotinamide Mononucleotide) should I take for Arterial Stiffness?
            
        
        

            Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of NMN (Nicotinamide Mononucleotide)?
            
        
        

            Reported side effects may include Generally well-tolerated, Mild gastrointestinal discomfort, Flushing (rare), Headache (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for NMN (Nicotinamide Mononucleotide) and Arterial Stiffness?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                

                    
इसके लिए अन्य सामग्री Arterial Stiffness

                    

                        
                        
                            Vitamin K2
                            B

                        
                        
                    

                

                

                
                

                    
NMN (Nicotinamide Mononucleotide) अन्य स्वास्थ्य स्थितियों के लिए

                    

                        
                        
                            Heart Failure
                            D

                        
                        
                    

                

                
            

        

        

    


    
    












    

        FDA अस्वीकरण:
        इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।